ASH | International Myeloma Foundation

Dr. Palmason address if Covid vaccines affects MGUS progression.

December 16

Does SARS-CoV-2 Vaccination Impact the Risk of Progression from MGUS to MM?

Dr. Ferreri on real world outcomes with Ide-Cel and BCMA-TT

December 16

Real-world Outcomes for Patients Treated with Ide-Cel after having Previously Received a BCMA-Targeted Therapy

Dr. Palmason ASH Abstract M-Proteins

December 15

Transient M-Proteins: Epidemiology, Causes, and the Impact of Mass Spectrometry: The iStopMM Study

Dr. Romano on the effects of Arginine Deprivation in Multiple Myeloma

December 15

Effects of Arginine Deprivation to Proteasome Inhibitor Resistance in Multiple Myeloma

Pair of scientists analyze data in research lab

Week in Review

December 14

Top Abstracts of Interest at the ASH 2022 Myeloma Sessions

Dr. Leon Bernal-Mizrachi

December 13

Association of Socioeconomic Status with Adherence, Progression Free and Overall Survival to Oral Agents in Multiple Myeloma Patients

2022 ASH Abstracts Preview

Week in Review

November 10

A Big Picture Preview of the 2022 ASH Annual Meeting

Hospital staff claps as African American senior in wheelchair is released

Clinical Trials and Treatments

May 5

Studies on Disparities in Myeloma Presented at ASH

Best of ASH 2021

December 16

Best of ASH 2021 Webinar

IMWG Conference Series Banner ASH 2021

December 13

IMWG Conference Series: ASH 2021

iStopmm Study abstracts being presented at ASH 2021

December 8

How important are the four iStopMM abstracts being presented at ASH for myeloma patients?

Covid-19 illustration

Week in Review

December 2

ASH Meeting Collides With Emergence of Omicron Variant

Subscribe to ASH

Give Where Most Needed